Boston Scientific (BSX) Income towards Parent Company (2009 - 2026)
Boston Scientific (BSX) posted quarterly Income towards Parent Company of $905.0 million for Q2 2026, up 13.84% year-over-year from $795.0 million in Q2 2025, and down 32.36% on a QoQ basis from $1.3 billion in Q1 2026.
Boston Scientific (BSX) Income towards Parent Company (2009 - 2026) Analysis & Trends
Boston Scientific has reported Income towards Parent Company for 18 years, with the latest figure at $905.0 million in Q2 2026.
- Income towards Parent Company for Q2 2026 came in at $905.0 million, up 13.84% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.7 billion (up 46.88% YoY), and the FY2025 annual result was $2.9 billion, up 56.66% from the prior year.
- Income towards Parent Company fell to $905.0 million in Q2 2026, from $1.3 billion in the prior quarter.
- Over five years, Income towards Parent Company peaked at $1.3 billion in Q1 2026 and troughed at $111.0 million in Q1 2022.
- A 5-year average of $515.2 million and a median of $498.5 million in 2023 frame the typical range for Income towards Parent Company.
- The widest annual swing landed in 2022, when Income towards Parent Company tumbled 67.45%; it then surged 257.45% in 2023.
- A 5-year view of Income towards Parent Company shows it stood at $141.0 million in 2022, then surged by 257.45% to $504.0 million in 2023, then grew by 11.51% to $562.0 million in 2024, then rose by 19.22% to $670.0 million in 2025, then jumped by 35.07% to $905.0 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were $905.0 million in Q2 2026, $1.3 billion in Q1 2026, and $670.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 905.00 Mn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 670.00 Mn |
| Sep 30, 2025 | 756.00 Mn |
| Jun 30, 2025 | 795.00 Mn |
| Mar 31, 2025 | 672.00 Mn |
| Dec 31, 2024 | 562.00 Mn |
| Sep 30, 2024 | 469.00 Mn |
| Jun 30, 2024 | 322.00 Mn |
| Mar 31, 2024 | 493.00 Mn |
| Dec 31, 2023 | 504.00 Mn |
| Sep 30, 2023 | 505.00 Mn |
| Jun 30, 2023 | 270.00 Mn |
| Mar 31, 2023 | 313.00 Mn |
| Dec 31, 2022 | 141.00 Mn |
| Sep 30, 2022 | 188.00 Mn |
| Jun 30, 2022 | 260.00 Mn |
| Mar 31, 2022 | 111.00 Mn |
| Dec 31, 2021 | 93.00 Mn |
| Sep 30, 2021 | 419.00 Mn |